Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Jan 10, 2020
Date Accepted: May 14, 2020

The final, peer-reviewed published version of this preprint can be found here:

Recruiting Adolescents With Chronic Fatigue Syndrome/Myalgic Encephalomyelitis to Internet-Delivered Therapy: Internal Pilot Within a Randomized Controlled Trial

Anderson E, Parslow R, Hollingworth W, Mills N, Beasant L, Gaunt D, Metcalfe C, Kessler D, Macleod J, Pywell S, Pitts K, Price S, Stallard P, Knoop H, Van de Putte E, Nijhof S, Bleijenberg G, Crawley E

Recruiting Adolescents With Chronic Fatigue Syndrome/Myalgic Encephalomyelitis to Internet-Delivered Therapy: Internal Pilot Within a Randomized Controlled Trial

J Med Internet Res 2020;22(8):e17768

DOI: 10.2196/17768

PMID: 32784188

PMCID: 7450376

Testing the feasibility of recruiting adolescents with CFS/ME to Internet-delivered therapy: Internal pilot within a randomised controlled trial (the ‘FITNET-NHS’ trial)

  • Emma Anderson; 
  • Roxanne Parslow; 
  • William Hollingworth; 
  • Nicola Mills; 
  • Lucy Beasant; 
  • Daisy Gaunt; 
  • Christopher Metcalfe; 
  • David Kessler; 
  • John Macleod; 
  • Susan Pywell; 
  • Kieren Pitts; 
  • Simon Price; 
  • Paul Stallard; 
  • Hans Knoop; 
  • Elise Van de Putte; 
  • Sanne Nijhof; 
  • Gijs Bleijenberg; 
  • Esther Crawley

ABSTRACT

Background:

Chronic fatigue syndrome (CFS/ME) in adolescents is common and disabling. UK teenagers are more likely to recover if they access specialist care, but most do not have access to a local specialist CFS/ME service. Delivering treatment remotely via the internet could improve access to treatment.

Objective:

To assess: i) the feasibility of recruitment and retention into a trial of internet-delivered specialist treatment for adolescent CFS/ME ii) the acceptability of trial processes and the two online treatments (to inform continuation to full trial).

Methods:

Design: Internal pilot for the initial 12 months of a full randomised controlled trial, with integrated qualitative methods (analysis of recruitment consultations and participant and clinician interviews). Setting: Remotely-delivered recruitment and treatment from a specialist paediatric CFS/ME treatment service within a south-west UK hospital. Participants: Adolescents (aged 11-17 years) from across the UK with a diagnosis of CFS/ME and no access to local specialist treatment were referred by their GP to the treatment centre. Eligibility assessment and recruitment were conducted via remote methods (telephone and online) and participants were randomised to one of two online treatments. Interventions: FITNET-NHS, an online modular CFS/ME-specific Cognitive Behaviour Therapy program (designed to be used by young people and their parents) supported by individualised clinical psychologist e-consultations. The comparison, Skype-delivered Activity Management with a CFS/ME clinician (mainly physiotherapist/occupational therapist). Both treatments were intended to last up to 6 months. Primary outcomes: Number of participants recruited (per out-of-area referrals received between 1 November 2016 to 31 October 2017), and proportion providing 6-month outcome data; qualitative outcomes indicating acceptability of trial processes and treatments.

Results:

89 young people (59% of 150 potentially eligible referrals) and their parents/carers were recruited and 75 (84% of 89) provided 6-month outcome data. Overall, online treatment was felt to be acceptable, however, participants and clinicians described both the advantages and disadvantages of remote methods.

Conclusions:

Recruiting young people (and parents/carers) into a randomised controlled trial of online treatment via remote methods is feasible and acceptable. Specialist treatment delivered at home via the Internet is feasible and acceptable, though some families prefer to travel across the UK for face-to-face treatment. Clinical Trial: International Standard Randomized Controlled Trial Number (ISRCTN) registered, 4 August, 2016: ISRCTN18020851


 Citation

Please cite as:

Anderson E, Parslow R, Hollingworth W, Mills N, Beasant L, Gaunt D, Metcalfe C, Kessler D, Macleod J, Pywell S, Pitts K, Price S, Stallard P, Knoop H, Van de Putte E, Nijhof S, Bleijenberg G, Crawley E

Recruiting Adolescents With Chronic Fatigue Syndrome/Myalgic Encephalomyelitis to Internet-Delivered Therapy: Internal Pilot Within a Randomized Controlled Trial

J Med Internet Res 2020;22(8):e17768

DOI: 10.2196/17768

PMID: 32784188

PMCID: 7450376

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.